Compare ERAS & URBN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ERAS | URBN |
|---|---|---|
| Founded | 2018 | 1970 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Clothing/Shoe/Accessory Stores |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.5B | 5.9B |
| IPO Year | 2021 | 1995 |
| Metric | ERAS | URBN |
|---|---|---|
| Price | $12.64 | $76.51 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 12 | 12 |
| Target Price | $14.25 | ★ $86.91 |
| AVG Volume (30 Days) | ★ 7.0M | 1.3M |
| Earning Date | 05-08-2026 | 05-20-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 36.23 | 18.78 |
| EPS | N/A | ★ 5.06 |
| Revenue | N/A | ★ $6,165,376,000.00 |
| Revenue This Year | N/A | $10.67 |
| Revenue Next Year | N/A | $7.01 |
| P/E Ratio | ★ N/A | $14.85 |
| Revenue Growth | N/A | ★ 11.07 |
| 52 Week Low | $1.12 | $59.54 |
| 52 Week High | $24.28 | $84.35 |
| Indicator | ERAS | URBN |
|---|---|---|
| Relative Strength Index (RSI) | 51.57 | 64.72 |
| Support Level | $1.76 | $72.41 |
| Resistance Level | $16.14 | $78.64 |
| Average True Range (ATR) | 0.71 | 2.78 |
| MACD | 0.38 | 0.66 |
| Stochastic Oscillator | 91.53 | 91.39 |
Erasca Inc is a clinical-stage precision oncology company singularly focused on discovering, developing, and commercializing therapies for patients with RAS/MAPK pathway-driven cancers. Its focused RAS/MAPK pathway pipeline comprises modality-agnostic programs aligned with three therapeutic strategies of: targeting key upstream and downstream signaling nodes in the RAS/MAPK pathway; targeting RAS directly; and targeting escape routes that emerge in response to treatment. Its pipeline includes two clinical-stage programs (ERAS-0015, a pan-RAS molecular glue; and ERAS-4001, a pan-KRAS inhibitor), and ERAS-12, a discovery-stage program.
Founded in 1970, Philadelphia-based Urban Outfitters is a multibrand apparel and home goods retailer that operates nearly 800 stores and e-commerce in the US, which accounts for about 87% of sales, as well as in other regions. Its retail nameplates are Urban Outfitters (22% of fiscal 2026 sales), Free People/Movement (26%), and Anthropologie (42%). Retail accounted for 86% of fiscal 2026 revenue, but Urban Outfitters also sells products through a wholesale operation, owns some restaurants, and operates a fast-growing clothing rental and resale business called Nuuly (9% of sales). Urban Outfitters primarily markets to young adults and offers products across apparel (66% of sales), home goods (16% of sales), accessories (13% of sales), and more.